- Home
- GROY vs XBIT Comparison
GROY vs XBIT Comparison
Compare GROY & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- XBIT
- Stock Information
- Founded
- GROY 2020
- XBIT 2005
- Country
- GROY Canada
- XBIT United States
- Employees
- GROY N/A
- XBIT N/A
- Industry
- GROY
- XBIT Pharmaceuticals and Biotechnology
- Sector
- GROY
- XBIT Health Care
- Exchange
- GROY Nasdaq
- XBIT Nasdaq
- Market Cap
- GROY 206.6M
- XBIT 194.5M
- IPO Year
- GROY 2021
- XBIT 2015
- Fundamental
- Price
- GROY $1.41
- XBIT $2.99
- Analyst Decision
- GROY Strong Buy
- XBIT
- Analyst Count
- GROY 4
- XBIT 0
- Target Price
- GROY $3.31
- XBIT N/A
- AVG Volume (30 Days)
- GROY 1.1M
- XBIT 54.9K
- Earning Date
- GROY 03-19-2025
- XBIT 03-14-2025
- Dividend Yield
- GROY N/A
- XBIT N/A
- EPS Growth
- GROY N/A
- XBIT N/A
- EPS
- GROY N/A
- XBIT N/A
- Revenue
- GROY $7,764,000.00
- XBIT N/A
- Revenue This Year
- GROY $270.34
- XBIT N/A
- Revenue Next Year
- GROY $119.32
- XBIT N/A
- P/E Ratio
- GROY N/A
- XBIT N/A
- Revenue Growth
- GROY 197.02
- XBIT N/A
- 52 Week Low
- GROY $1.16
- XBIT $2.99
- 52 Week High
- GROY $2.21
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- GROY 54.53
- XBIT 31.96
- Support Level
- GROY $1.40
- XBIT $3.03
- Resistance Level
- GROY $1.49
- XBIT $3.32
- Average True Range (ATR)
- GROY 0.07
- XBIT 0.19
- MACD
- GROY -0.00
- XBIT 0.04
- Stochastic Oscillator
- GROY 47.83
- XBIT 0.00
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.